Clinical Trial Update: PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk [NA]

View source ↗

Summary

Completed clinical trial of the Edwards Lifesciences PARTNER II study evaluating transcatheter aortic valve replacement in intermediate and high-risk patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Severe Aortic Stenosis

Drugs mentioned

• Aortic Valve Transcatheter (2nd generation) devices

Snippet

Sponsor: Edwards Lifesciences | Conditions: Symptomatic Severe Aortic Stenosis | NA | Status: COMPLETED | Results posted: 2018-08-14